Clovis Oncology Inc (CLVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLVS | NRSN | CSCI | ||
| Company | Clovis Oncology Inc | Neurosense Therapeutics Ltd | Cosciens Biopharma Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.0808 | 0.9801 | 2.82 | ||
| High | 0.0977 | 1.0199 | 2.82 | ||
| Low | 0.0766 | 0.9800 | 2.80 | ||
| Last | 0.0812 | 0.9895 | 2.80 | ||
| Change | -0.0048 | -0.0006 | -0.18 | ||
| % Change | -5.58% | -0.06% | -6.07% | ||
| Volume | 24,516,400 | 11,064 | 1,793 | ||
| 20-Day Average Volume | 9,433,500 | 190,791 | 6,725 | ||
| Previous Close | 0.0860 | 0.9901 | 2.98 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.2340 | 1.2452 | 3.38 | ||
| 20-Day Raw Stochastic | 1.73% | 4.63% | 0.88% | ||
| 20-Day Relative Strength | 23.83% | 36.79% | 30.74% | ||
| Weighted Alpha | -91.19 | -30.34 | -61.71 | ||
| Today's Opinion | 100% Sell | 8% Sell | 100% Sell | ||
| Previous Opinion | 100% Sell | 8% Sell | 100% Sell | ||
| Last Month's Opinion | 100% Sell | 8% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -39.04% since 12/13/22 | -23.85% since 11/14/24 | -10.18% since 11/14/24 | ||
| Low | 0.0760 on 12/16/22 | 0.9701 on 11/20/24 | 2.82 on 11/21/24 | ||
| High | 0.1439 on 12/14/22 | 1.2814 on 11/15/24 | 3.31 on 11/15/24 | ||
| 1-Month | |||||
| %Chg | -76.74% since 11/18/22 | -10.00% since 10/21/24 | -23.78% since 10/21/24 | ||
| Low | 0.0760 on 12/16/22 | 0.9701 on 11/20/24 | 2.81 on 11/12/24 | ||
| High | 0.3772 on 12/01/22 | 1.4000 on 10/29/24 | 3.90 on 11/05/24 | ||
| 3-Month | |||||
| %Chg | -92.75% since 09/20/22 | +22.22% since 08/21/24 | -51.88% since 08/21/24 | ||
| Low | 0.0760 on 12/16/22 | 0.6729 on 08/28/24 | 2.81 on 11/12/24 | ||
| High | 1.3100 on 10/04/22 | 1.4550 on 09/16/24 | 6.18 on 08/23/24 | ||
| 6-Month | |||||
| %Chg | -93.12% since 06/17/22 | -21.43% since 05/21/24 | -66.31% since 05/21/24 | ||
| Low | 0.0760 on 12/16/22 | 0.5120 on 07/19/24 | 2.81 on 11/12/24 | ||
| High | 3.2500 on 07/08/22 | 1.5000 on 07/02/24 | 11.10 on 05/29/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 11,770 | 13,531 | 11,200 | ||
| Shares Outstanding, K | 144,955 | 13,666 | 3,757 | ||
| Annual Sales | 148,760,000 | 0 | 4,500,000 | ||
| Annual Net Income | -264,520,000 | -11,280,000 | -16,550,000 | ||
| Last Quarter Sales | 30,660,000 | 0 | 1,870,000 | ||
| Last Quarter Net Income | -56,010,000 | -5,400,000 | -5,760,000 | ||
| 60-Month Beta | 0.24 | 1.58 | 1.54 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.39 on 11/09/22 | -0.35 on 06/24/24 | -1.85 on 11/12/24 | ||
| Latest Earnings Date | 11/09/22 | 11/26/24 | 11/14/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||